These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3787710)

  • 1. Cyclosporine and analogues: structural requirements for immunosuppressive activity.
    Wenger R
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):213-8. PubMed ID: 3787710
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis of ciclosporin and analogues: structural and conformational requirements for immunosuppressive activity.
    Wenger RM
    Prog Allergy; 1986; 38():46-64. PubMed ID: 3725755
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclosporine: conformation and analogues as tools for studying its mechanism of action.
    Wenger RM
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):313-8. PubMed ID: 3363641
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclosporins. Structure-activity relationships.
    Fliri H; Baumann G; Enz A; Kallen J; Luyten M; Mikol V; Movva R; Quesniaux V; Schreier M; Walkinshaw M
    Ann N Y Acad Sci; 1993 Nov; 696():47-53. PubMed ID: 8109856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporine and analogues--isolation and synthesis--mechanism of action and structural requirements for pharmacological activity.
    Wenger RM
    Fortschr Chem Org Naturst; 1986; 50():123-36. PubMed ID: 3546034
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclosporine A in contrast to a cyclosporine metabolite (OL-17) specifically inhibits growth of renal cells in culture.
    Cole E; Skorecki K; Cheung F; Wong PY; Fung LS; Levy GA
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):732-7. PubMed ID: 3388511
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of the pharmacological profiles of cyclosporine, (Nva2)-cyclosporine and (Val2)dihydro-cyclosporine.
    Hiestand PC; Gunn HC; Gale JM; Ryffel B; Borel JF
    Immunology; 1985 Jun; 55(2):249-55. PubMed ID: 3891595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of cyclosporine G (OG37-325), cyclosporine A, and their metabolites on the release of vasoactive substances from primary renal cell lines.
    Langman LJ; Yatscoff RW
    Transplant Proc; 1994 Oct; 26(5):3002-5. PubMed ID: 7940948
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclosporins: lack of correlation between antischistosomal properties and inhibition of cyclophilin isomerase activity.
    Khattab A; Pica-Mattoccia L; Klinkert MQ; Wenger R; Cioli D
    Exp Parasitol; 1998 Sep; 90(1):103-9. PubMed ID: 9709036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and identification of novel colchicine-derived immunosuppressant.
    Chang DJ; Yoon EY; Lee GB; Kim SO; Kim WJ; Kim YM; Jung JW; An H; Suh YG
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4416-20. PubMed ID: 19502058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cyclosporine and some derivatives on chronic rejection.
    Lu X; Dawson J; Borel JF
    Transplant Proc; 1996 Dec; 28(6):3152-3. PubMed ID: 8962221
    [No Abstract]   [Full Text] [Related]  

  • 12. New cyclosporine derivative SDZ IMM 125: in vitro and in vivo pharmacologic effects and toxicologic evaluation.
    Hiestand PC; Gräber M; Hurtenbach U; Herrmann P; Cammisuli S; Richardson BP; Eberle MK; Donatsch P; Ryffel B; Borel JF
    Transplant Proc; 1993 Feb; 25(1 Pt 1):691-2. PubMed ID: 8438439
    [No Abstract]   [Full Text] [Related]  

  • 13. Nephrotoxic and immunosuppressive potentials of cyclosporine metabolites in rats.
    Ryffel B; Hiestand P; Foxwell B; Donatsch P; Boelsterli HJ; Maurer G; Mihatsch MJ
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):41-5. PubMed ID: 3787715
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclosporine and murine allergic contact dermatitis.
    Rullan PP; Barr RJ; Cole GW
    Arch Dermatol; 1984 Sep; 120(9):1179-83. PubMed ID: 6332577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similarities and differences in the structure-activity relationships of capsaicin and resiniferatoxin analogues.
    Walpole CS; Bevan S; Bloomfield G; Breckenridge R; James IF; Ritchie T; Szallasi A; Winter J; Wrigglesworth R
    J Med Chem; 1996 Jul; 39(15):2939-52. PubMed ID: 8709128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive activity of [MeBm2t]1-, D-diaminobutyryl-8-, and D-diaminopropyl-8-cyclosporin analogues correlates with inhibition of calcineurin phosphatase activity.
    Nelson PA; Akselband Y; Kawamura A; Su M; Tung RD; Rich DH; Kishore V; Rosborough SL; DeCenzo MT; Livingston DJ
    J Immunol; 1993 Mar; 150(6):2139-47. PubMed ID: 7680683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of cyclosporine.
    Maurer G
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):19-26. PubMed ID: 3895660
    [No Abstract]   [Full Text] [Related]  

  • 18. Tetrazole analogues of cyclolinopeptide A: synthesis, conformation, and biology.
    Kaczmarek K; Jankowski S; Siemion IZ; Wieczorek Z; Benedetti E; Di Lello P; Isernia C; Saviano M; Zabrocki J
    Biopolymers; 2002 May; 63(6):343-57. PubMed ID: 11920436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of cyclosporine on cardiac xenograft survival.
    Sugimoto K; Shelby J; Corry RJ
    Transplantation; 1985 Feb; 39(2):218-9. PubMed ID: 3881859
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclosporine: a new and promising immunosuppressive agent.
    Flechner SM
    Urol Clin North Am; 1983 May; 10(2):263-75. PubMed ID: 6304967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.